Since Fn and ETBF are enriched in early stages of tumorigenesis (premalignant lesions and adenomas) in CRC patients [53–57], we sacrificed mice at 11-weeks of age corresponding to 5 weeks post-pathobiont exposure or PBS treatment. This evidence concerns the gene FN1 and adenoma.